Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.
There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

UFS appoints new council members
2004-06-07

 

The council of the University of the Free State (UFS) last week appointed two new council members. One of the members, Mrs Busiswa Tshabalala, will represent the Qwaqwa community. It is the first time since the incorporation of the Qwaqwa into the UFS campus last year that a council member was elected to represent the Qwaqwa community.

Mrs Tshabalala obtained her BA Hons in History from the University of the North’s Qwaqwa campus in 1992 and a B Ed degree in leadership management from the UFS in 1998. She was the first female deputy principal at the Harrismith Secondary School (1989-1992) and principal of the Forty Second Hill Teachers’ Centre in the Vrede area office of the Free State Department of Education. In 2001 she was seconded by the Free State Department of Education to coordinate programme 1 and 2 for Link Community Development. She is currently the director of the Thabo Mofutsanyana education district of the Free State Department of Education.

Dr Susan Vosloo, international acclaimed cardiologist, is the other new member of the council. Dr Vosloo, old Kovsie of the year 1989, obtained the MB Chb degree in 1980 at the UFS, an M Med cardiothoracic surgery and in 1998 the FCS (SA) qualification in cardiothoracic surgery at the College of Medicine of South Africa (CMSA). Dr Vosloo’s career extends over a wide spectrum and she specialises in pediatric and adult cardiothoracic surgery. In 1993 she took part in the first heart transplant in Johannesburg at Milpark Hospital, in 1997 she did the first hear-lung transplant at City Park Hospital in Cape Town and in 1997 a heart transplant on a 3-year old child.

She has a cardiothoracic surgery at the Christiaan Barnard Memorial Hospital in Cape Town since 1991 and in also part-time involved with the Red Cross Memorial Hospital in Cape Town.

“It is a great honour for the UFS to welcome two women with so much expertise and experience on the council. Their presence strengthens the UFS’s continued effort to transform the council,” said judge Faan Hancke, chairperson of the UFS council..

Both Mrs Tshabalala and Dr Vosloo’s appointments are until June 2008.

The following council members have been re-elected until June 2008:

Prof Dines Gihwala - vice-chairperson of the council
Dr Nathan Bagarette
Dr Frans Kotzé

Dr Kobus Laubscher was elected by the donors as representative for a further term until June 2008. Me Winifred Hoexter was elected by the Alumni as the third representative. She has been a foundation donor of the UFS since 1997 and committee member of the Kovsie Alumni Trust since 2000. Me Hoexter’s term is until June 2008. The other Alumni representatives are judge Faan Hancke and Mr Jan Grobler, whose term is until June 2006.


Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za

7 June 2004

 

 

Mrs Busiswa Tshabalala

Dr Susan Vosloo

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept